ROGERS MICHAEL W
SEC CIK 1244159 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKBA | Akebia Therapeutics, Inc. | Dir | 197.4K | — | — | 5 | 2022-06-08 | 2026-06-17 |
Most active insiders at AKBA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Butler John P. | CEO, Pres, Dir | $86.6K | $474.4K |
| 2 | Grund Nicholas | Chief Commercial Off | — | $117.9K |
| 3 | Ostrowski Erik | SVP, CFO, CBO, Treas | — | $110.8K |
| 4 | Rucci Carolyn M. | SVP, CLO | — | $97.0K |
| 5 | Burke Steven Keith | SVP, Chief Medical Off | — | $94.0K |
| 6 | Malabre Richard C | SVP, CAO | — | $68.8K |
| 7 | FRIESON RON | Dir | — | — |
| 8 | Wolf Myles | Dir | — | — |
| 9 | Smith Cynthia | Dir | — | — |
| 10 | ADAMS ADRIAN | Dir | — | — |
| 11 | ROGERS MICHAEL W | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-22 16:22 | 2026-06-17 | AKBA | Akebia Therapeutics, Inc. | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +35.7K | 197.4K | +22% | $0 |
| D | 2025-06-11 | 2025-06-10 | AKBA | Akebia Therapeutics, Inc. | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +35.7K | 161.7K | +28% | $0 |
| D | 2024-06-10 | 2024-06-06 | AKBA | Akebia Therapeutics, Inc. | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +30.0K | 126.0K | +31% | $0 |
| D | 2023-06-08 | 2023-06-06 | AKBA | Akebia Therapeutics, Inc. | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +30.0K | 96.0K | +45% | $0 |
| D | 2022-06-09 | 2022-06-08 | AKBA | Akebia Therapeutics, Inc. | ROGERS MICHAEL W | Dir | A - Grant | $0.00 | +13.7K | 66.0K | +26% | $0 |
Purchase Sale Sale after option exercise All abbreviations